![Mensaje del CEO de Pfizer al público: confíen en nosotros con el refuerzo de la vacuna contra covid | Kaiser Health News Mensaje del CEO de Pfizer al público: confíen en nosotros con el refuerzo de la vacuna contra covid | Kaiser Health News](https://khn.org/wp-content/uploads/sites/2/2021/08/GettyImages-1233376539.jpg?w=1270)
Mensaje del CEO de Pfizer al público: confíen en nosotros con el refuerzo de la vacuna contra covid | Kaiser Health News
![With FDA approval of Pfizer COVID-19 vaccine, vaccinations remain top of mind for metro Atlanta health care systems With FDA approval of Pfizer COVID-19 vaccine, vaccinations remain top of mind for metro Atlanta health care systems](https://news.emory.edu//stories/2021/08/pfizer_vaccine_fda_approval_joint_hospitals_press_conference/thumbs/receiving_vaccine.jpg)
With FDA approval of Pfizer COVID-19 vaccine, vaccinations remain top of mind for metro Atlanta health care systems
![Baker-Polito Administration Encourages COVID-19 Boosters for All Fully Vaccinated Individuals 18+ | Mass.gov Baker-Polito Administration Encourages COVID-19 Boosters for All Fully Vaccinated Individuals 18+ | Mass.gov](https://www.mass.gov/files/styles/1670x/public/2021-11/Booster_General_18Plus_SocialMedia_Sizes_1920x1080.png?itok=HIiLujC4)
Baker-Polito Administration Encourages COVID-19 Boosters for All Fully Vaccinated Individuals 18+ | Mass.gov
![Invima on Twitter: "Aplicación de la vacuna Pfizer-BioNTech contra covid -19 a mujeres gestantes y lactantes. Lee la nota completa 👉 https://t.co/sLh6LsUg3v https://t.co/5VGzmV9r8D" / Twitter Invima on Twitter: "Aplicación de la vacuna Pfizer-BioNTech contra covid -19 a mujeres gestantes y lactantes. Lee la nota completa 👉 https://t.co/sLh6LsUg3v https://t.co/5VGzmV9r8D" / Twitter](https://pbs.twimg.com/media/E5zOWEXXIAInAwE.jpg)
Invima on Twitter: "Aplicación de la vacuna Pfizer-BioNTech contra covid -19 a mujeres gestantes y lactantes. Lee la nota completa 👉 https://t.co/sLh6LsUg3v https://t.co/5VGzmV9r8D" / Twitter
![Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against SARS-CoV-2 – Virginia Chamber of Commerce Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against SARS-CoV-2 – Virginia Chamber of Commerce](https://mms.businesswire.com/media/20200701005576/en/337677/4/pfizer_rgb_pos.jpg)